Bifidobacterium bifidum R0071
Bifidobacterium bifidum strain R0071 is a gram-positive anaerobic bacterium native to the human gastrointestinal tract. Research includes animal studies of its immunomodulatory and mucin-regulating effects, in vitro investigation of its interactions with human milk oligosaccharides, and randomized controlled trials examining its associations with changes in gut microbiota, immune function, and gastrointestinal symptoms in infants and healthy adults.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 20 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 8 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
24 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 42598364 →Precision synbiotic intervention with 2′-fucosyllactose and infant-derived Bifidobacterium modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial· Frontiers in Nutrition · 2026
-
[2]
Source →Mapping probiotic interactions with human milk oligosaccharides· · 2025
-
[3]
Source →Bifidobacterium bifidum R0071 decreases stress‐associated diarrhea‐related symptoms and ultimately self‐reported stress in a randomized, double‐blind, placebo‐controlled study (647.21)· The FASEB Journal · 2014